Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results

Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.

For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
• Cummins wins battery storage contract for U.S. data center project